SCHEDULE: Nantahala Capital Amends uniQure Stake to 3.75%

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, filed an amendment to their Schedule 13G, disclosing a 3.75% beneficial ownership in uniQure N.V. as of June 30, 2025.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack (the "Reporting Persons") collectively hold beneficial ownership of 2,051,852 Ordinary Shares of uniQure N.V.
• This represents 3.75% of uniQure N.V.'s outstanding Ordinary Shares.
• The Reporting Persons have shared voting power and shared dispositive power over all 2,051,852 shares.
• Nantahala Capital Management, LLC is an investment adviser, and Messrs. Harkey and Mack are its managing members and control persons.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of uniQure N.V.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual disclosure of beneficial ownership and does not contain information that would inherently indicate positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of passive beneficial ownership by an institutional investor in a biotechnology company. It does not provide specific insights into uniQure N.V.'s operational performance or strategic direction, nor does it indicate any broader industry trends beyond the investor's continued interest in the sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant passive ownership stakes, confirming that a notable institutional investor maintains a position in the company without intent to influence control.

Key Dates

Keywords

uniQure N.V., Nantahala Capital Management, Wilmot B. Harkey, Daniel Mack, Beneficial Ownership, SEC Filing, Schedule 13G, Investment Management, Biotechnology, Gene Therapy